Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial
暂无分享,去创建一个
C. Molina | J. Montaner | J. Álvarez-Sabín | M. Millán | J. Krupiński | F. Rubio | M. Quintana | P. Chacón | P. Hereu | Manolo Quintana | Jerzy Krupinski | Pilar Chacón | Francisco Rubio | Mónica Millán | C. A. Molina
[1] M. Hennerici,et al. High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.
[2] M. Chopp,et al. Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat , 2005, Circulation.
[3] 曲东锋. Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .
[4] C. Weber,et al. HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis , 2004, Circulation.
[5] S. Warach,et al. Rising statin use and effect on ischemic stroke outcome , 2004, BMC medicine.
[6] Yaniv Almog,et al. Statins, inflammation, and sepsis: hypothesis. , 2003, Chest.
[7] Jian‐Jun Li,et al. Simvastatin inhibits interleukin‐6 release in human monocytes stimulated by C‐reactive protein and lipopolysaccharide , 2003, Coronary artery disease.
[8] C. Vaughan. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. , 2003, The American journal of cardiology.
[9] E. Tremoli,et al. Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[10] K. Hirata,et al. HMG-CoA Reductase Inhibitor Has Protective Effects Against Stroke Events in Stroke-Prone Spontaneously Hypertensive Rats , 2003, Stroke.
[11] M. Ezekowitz,et al. Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy , 2002, Circulation.
[12] P. Kivisäkk,et al. Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. , 1999, Stroke.
[13] N. Delanty,et al. Neuroprotective properties of statins in cerebral ischemia and stroke. , 1999, Stroke.
[14] S. Ekholm,et al. Intrathecal expression of proteins regulating apoptosis in acute stroke. , 1999, Stroke.
[15] M. Essig,et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. , 1998, Circulation research.
[16] M. Moskowitz,et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[18] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[19] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[20] J. Goldstein,et al. Regulation of the mevalonate pathway , 1990, Nature.